Next 10 |
FREMONT, CA - ( NewMediaWire ) - July 02, 2024 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, CNS (central nervous systems), and oncology/hematology, announced today that the Company and it...
The Company holds a U.S. patent for the same treatment FREMONT, CA - ( NewMediaWire ) - June 25, 2024 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, neurology, a...
2024-06-21 17:26:44 ET More on ABVC BioPharma ABVC BioPharma executes licensing agreement with OncoX ABVC Biopharma stock climbs on deal for its oncology/hematology products Financial information for ABVC BioPharma Read the full article on Seeking Alpha ...
FREMONT, CA - ( NewMediaWire ) - June 12, 2024 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, CNS (central nervous systems), and oncology/hematology, announced today that the Company receive...
US FDA-IND 131300 (ABV-1702) FREMONT, CA - ( NewMediaWire ) - May 24, 2024 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, CNS (central nervous systems), and Oncol...
FREMONT, CA - ( NewMediaWire ) - May 22, 2024 - – ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, neurology, and oncology/hematology, today published a Corporate...
FREMONT, CA - ( NewMediaWire ) - May 15, 2024 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, CNS (central nervous systems), and Oncology/Hematology, announced today ...
FREMONT, CA - ( NewMediaWire ) - May 09, 2024 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, CNS (central nervous systems), and Oncology/Hematology, announced today that in its fi...
2024-04-29 08:36:50 ET More on premarket gainers & stock Diving Into Deciphera Pharmaceuticals Fulton Financial Corporation (FULT) Q1 2024 Earnings Call Transcript Fulton Financial Corporation 2024 Q1 - Results - Earnings Call Presentation Fulton Financia...
2024-04-24 09:12:50 ET More on premarket gainers and stock Altamira Therapeutics Ltd. 2023 Q4 - Results - Earnings Call Presentation Altamira Therapeutics Ltd. (CYTO) Q4 2023 Earnings Call Transcript B. Riley Financial: Audit Risk May Have Potential Rewards B...
News, Short Squeeze, Breakout and More Instantly...
FREMONT, CA - ( NewMediaWire ) - July 02, 2024 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, CNS (central nervous systems), and oncology/hematology, announced today that the Company and it...
The Company holds a U.S. patent for the same treatment FREMONT, CA - ( NewMediaWire ) - June 25, 2024 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, neurology, a...
FREMONT, CA - ( NewMediaWire ) - June 12, 2024 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, CNS (central nervous systems), and oncology/hematology, announced today that the Company receive...